A University of Bath spin-out business is to commercialise its world-beating 100% needle-free blood sugar monitor in a move that could have huge applications for chronic diseases such as diabetes. Transdermal Diagnostics, which was launched in March, has raised £1.1m in a pre-seed round investment to further develop and bring to market its pioneering...